CN116730988A - 一种三嗪类化合物、其中间体、其制备方法及其用途 - Google Patents

一种三嗪类化合物、其中间体、其制备方法及其用途 Download PDF

Info

Publication number
CN116730988A
CN116730988A CN202310232863.0A CN202310232863A CN116730988A CN 116730988 A CN116730988 A CN 116730988A CN 202310232863 A CN202310232863 A CN 202310232863A CN 116730988 A CN116730988 A CN 116730988A
Authority
CN
China
Prior art keywords
group
hydrogen
alkyl
methyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310232863.0A
Other languages
English (en)
Chinese (zh)
Inventor
沈孝坤
黄金文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hubei Jiukangtong Biopharmaceutical Co ltd
Original Assignee
Hubei Jiukangtong Biopharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hubei Jiukangtong Biopharmaceutical Co ltd filed Critical Hubei Jiukangtong Biopharmaceutical Co ltd
Publication of CN116730988A publication Critical patent/CN116730988A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/08—Acetic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C07C57/15—Fumaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CN202310232863.0A 2022-03-10 2023-03-10 一种三嗪类化合物、其中间体、其制备方法及其用途 Pending CN116730988A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN202210245736X 2022-03-10
CN202210245736 2022-03-10
CN202210557410 2022-05-20
CN2022105574100 2022-05-20

Publications (1)

Publication Number Publication Date
CN116730988A true CN116730988A (zh) 2023-09-12

Family

ID=87905051

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310232863.0A Pending CN116730988A (zh) 2022-03-10 2023-03-10 一种三嗪类化合物、其中间体、其制备方法及其用途

Country Status (8)

Country Link
US (1) US20250188102A1 (enExample)
EP (1) EP4491623A4 (enExample)
JP (1) JP2025510603A (enExample)
KR (1) KR20250002216A (enExample)
CN (1) CN116730988A (enExample)
AU (1) AU2023231321A1 (enExample)
CA (1) CA3248484A1 (enExample)
WO (1) WO2023169572A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116284133A (zh) * 2022-03-24 2023-06-23 南京知和医药科技有限公司 一种新型六元杂环类衍生物及其药物组合物和用途
CN116514784A (zh) * 2022-04-01 2023-08-01 深圳安泰维生物医药有限公司 一种三嗪类化合物及其用途

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3224494A1 (en) 2021-07-09 2023-01-12 Koen Vandyck Anti-viral compounds
KR20250046274A (ko) 2022-08-05 2025-04-02 길리애드 사이언시즈, 인코포레이티드 SARS-CoV2 주요 프로테아제 억제제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2604595T3 (pl) * 2010-08-10 2016-09-30 Pochodna triazyny i związek farmaceutyczny, który ją zawiera i wykazuje aktywność przeciwbólową
CN114539228A (zh) * 2022-03-14 2022-05-27 药康众拓(江苏)医药科技有限公司 三嗪类化合物或其可药用盐、异构体、药物组合物和用途
CN114507221B (zh) * 2022-04-21 2022-08-26 药康众拓(江苏)医药科技有限公司 一种三嗪类化合物及其在制备抗病毒药物上的用途
CN114790198B (zh) * 2022-06-24 2022-10-04 药康众拓(江苏)医药科技有限公司 一种三嗪类化合物及其制备方法和应用
CN116496266A (zh) * 2022-07-08 2023-07-28 歌礼生物科技（杭州）有限公司 三嗪衍生物

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116284133A (zh) * 2022-03-24 2023-06-23 南京知和医药科技有限公司 一种新型六元杂环类衍生物及其药物组合物和用途
CN116284133B (zh) * 2022-03-24 2024-03-29 南京知和医药科技有限公司 一种新型六元杂环类衍生物及其药物组合物和用途
CN116514784A (zh) * 2022-04-01 2023-08-01 深圳安泰维生物医药有限公司 一种三嗪类化合物及其用途

Also Published As

Publication number Publication date
KR20250002216A (ko) 2025-01-07
JP2025510603A (ja) 2025-04-15
AU2023231321A1 (en) 2024-10-31
EP4491623A1 (en) 2025-01-15
US20250188102A1 (en) 2025-06-12
EP4491623A4 (en) 2026-03-18
WO2023169572A1 (zh) 2023-09-14
CA3248484A1 (en) 2025-07-07

Similar Documents

Publication Publication Date Title
TWI753918B (zh) 作為ｊａｋ抑制劑的吡咯並嘧啶化合物的結晶
WO2023169572A1 (zh) 一种三嗪类化合物、其中间体、其制备方法及其用途
US8569319B2 (en) Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
CN106029659B (zh) 谷氨酰胺酶抑制剂
CN114008049A (zh) 用于癌症治疗的egfr抑制剂
JP2013525458A (ja) 抗癌及び抗増殖活性を示すシクロプロピルジカルボキサミド及び類似体
JPWO2010110231A1 (ja) 置換された３−ヒドロキシ−４−ピリドン誘導体
WO2023042879A1 (ja) ウイルス増殖阻害活性を有する二環性複素環誘導体およびそれらを含有する医薬組成物
TW201221518A (en) Compounds
CN102548987B (zh) 作为激酶抑制剂的氟取代化合物及其使用方法
TW200304824A (en) Nicotinamide derivatives useful as PDE4 inhibitors
WO2021115401A1 (zh) 具有大环结构的含氟并杂环衍生物及其用途
CN115960099A (zh) 一类芳环或芳基杂环并吡啶酮类化合物、药物组合物及其应用
WO2025167663A1 (zh) 哒嗪类化合物及其应用
JP2023525380A (ja) アザ縮合環状アミド化合物及びその用途
WO2017157137A1 (zh) 一种新型的无环核苷类似物及其药物组合物
WO2017148290A1 (zh) 一种取代的腺嘌呤化合物及其药物组合物
EP3964509B1 (en) Compound containing fused ring, use thereof and pharmaceutical composition containing same
WO2023169554A1 (zh) 甲硫氨酸腺苷转移酶抑制剂、其制备方法及应用
WO2023078267A1 (zh) 作为蛋白激酶调节剂的含氨基大环化合物
TWI753418B (zh) 抗b型肝炎病毒(hbv)之新穎草醯基哌嗪活性劑
CN102133217B (zh) 一类以n为桥键的哒嗪酮类化合物在制备抗肿瘤的药物中的用途
US11021479B2 (en) Pyridoquinazoline derivatives useful as protein kinase inhibitors
JPWO2006051937A1 (ja) ヘテロ５員環誘導体
US20260097029A1 (en) Tetrahydroquinoline Compounds As Antitumor Agents

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination